SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

The FDA has rejected vatiquinone, requesting that PTC run an additional study to prove the drug's efficacy prior to ...

In recent years, cell biology has been revolutionized by applying emerging bio/nanomaterials. These advancements, ...

Natco Pharma, with Lupen, launches Bosentan tablets in US after USFDA nod; bags 180-day exclusivity for treating pulmonary ...

MBX Biosciences Inc. (NASDAQ: MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX ...

Jaguar Health, Inc. ( NASDAQ: JAGX) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Carol R. Lizak - Chief Financial Officer Lisa A. Conte - Founder, CEO, President & Director ...

The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.

RVPH READ THE FULL RVPH RESEARCH REPORT Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 2Q:25 results, ...